Hydroxyurea treatment for unresectable meningioma;Traitement des méningiomes par hydroxyurée

Neurochirurgie

Volumn 50, Issue 4, 2004, Pages 461-467

  Fuentes, S ^a   Chinot, O ^a   Dufour, H ^a   Paz Paredes, A ^a   Metellus P H ^a   Barrie Attarian, M ^a   Grisoli, F ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Chemotherapy; Hydroxyurea; Meningioma

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYUREA;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; APHTHOUS STOMATITIS; ARTICLE; ASTHENIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL DOCUMENTATION; MENINGIOMA; NAUSEA; NEUROIMAGING; NEURORADIOLOGY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; SKIN DISEASE; SKIN ULCER; SKULL SURGERY; THROMBOCYTOPENIA; VISUAL DISORDER;

EID: 6344229902     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0028-3770(04)98326-9     Document Type: Article

References (34)

1. AL-RODHAN NRF, LAW ER. The history of intracranial meningiomas. In: AL-MELFTI O, ed. Meningiomas. New York: Raven Press, 1991: 1-8.
2. BLACK PM. Meningiomas. Neurosurgery 1993; 32: 643-657.
3. BONDY M, LIGON BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996; 29: 197-205.
4. BURGER PC, SCHEITHAUER BW. Tumors of meningothelial cells. In: ROSAI J, ed. Atlas of tumor pathology. Tumors of the central nervous system. Washington, DC: Armed Forced Institute of Pathology, 1994: 259-286.
5. CHAMBERLAIN MC. Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 1996; 84: 733-736.
6. DEMONTE F, AL-MELFTY O. Meningiomas. In: KAYE AH, LAWS Jr ER, eds. Brain tumors. Edinburgh: Churchill Livingstone, 1995: 675-704.
7. GOLDSMITH BL, WARA WM, WILSON CB, LARSON DA. Postoperative irradiation for subtotally resected meningiomas, a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994; 80: 195-201.
8. GOODWIN JW, CROWLEY J, EYRE HJ, STAFFORE B, JAECKLE KA, TOWNSEND JJ. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a South-West Oncologic Group Study. J Neurooncol 1993; 15: 75-77.
9. GRUNBERG SM, WEISS MH, SPITZ IM, AHMADI J, SADUN A, RUSSELL CA, et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 1991; 74: 861-866.
10. JÄÄSKELÄINEN J, HALTIA M, LAASONEN E, WAHLSTRÖM T, VALTONEN S. The growth rate of intracranial meningiomas and its relation to history: an analysis of 43 patients. Surg Neural 1985; 24: 165-172.
11. JÄÄSKELÄINEN J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factor predicting recurrence in 657 patients. A multivariate analysis. Surg Neural 1986; 26: 461-469.
12. JUNG HW, Yoo H, PAEK SH, CHOI KS. Long-term out-come and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases. Neurosurgery 2000; 46: 567-575.
13. KABA SE, DEMONTE F, BRUNER JM, KYRITSIS AP, JAECKLE KA, LEVIN V, et al. The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 1997; 40: 271-275.
14. KALLIO M, SANKILA R, HAKULINEN T, JÄÄSKELÄINEN J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningiomas. Neurosurgery 1992; 31: 2-12.
15. KYRITSIS AP. Chemotherapy for meningiomas. J Neurooncol 1996; 29: 269-272.
16. LANGFORD LA. Pathology of meningiomas. J Neurooncol 1996; 29: 217-221.
17. LUNSFORD LD. Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal? J Neurosurg 1994; 80: 187-190.
18. MAGUIRE PD, CLOUGH R, FRIEDMAN AH, HALPERIN EC. Fractionned external-beam radiation therapy for meningiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys 1999; 44: 75-79.
19. MAIER H, ÖFNER D, HITTMAIR A, KITZ K, BUDKA H. Classic, atypical, and anaplasic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77: 616-623.
20. MAIRE JP, CAUDRY M, GUÉRIN J, CÉLÉRIER D, SAN GALLI F, CAUSSE N, et al. Fractionated radiation therapy in the treatment of intracranial meningiomas: local control, functional efficacity, and tolerance in 91 patients. Int J Radiat Oncol Biol Phys 1995; 33: 315-321.
21. MAOR MH. Radiotherapy for meningiomas. J Neurooncol 1996; 29: 261-267.
22. MAROON JC, KENNERDELL JS, VIDOVICH D, ABLA A, STERNAU L. Recurrent spheno-orbital meningioma. J Neurosurg 1994; 80: 202-208.
23. NEWMAN SA. Meningiomas: a quest for the optimum therapy. J Neurosurg 1994; 80: 191-194.
24. NEWTON HB, SLIVKA MA, STEVEN C. Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 2000; 49: 165-170.
25. NUTTING C, BRADA M, BRAZIL L, SIBTAIN A, SARAN F, WESTBURY C, et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 1999; 90: 823-827.
26. OURA S, SAKURAI T, YOSHIMURA G, TAMAKI T, UMEMURA T, KOKAW Y, et al. Regression of a presumed meningioma with the antiestrogen agent: mepitiostane. Case report. J Neurosurg 2000; 93: 132-135.
27. PHILIPPON J. Les récidives des méningiomes sus-tentoriels. In: PHILIPPON J, ed. Les méningiomes récidivants. Neurochirurgie (suppl) 1986; 32: 6-53.
28. RODRIGUEZ LA, PRADOS M, DAVID R. Malignant meningiomas: an analysis of 35 cases. J Neurosurg 1989; 70: 318A (abstract).
29. SALAZAR OM. Ensuring local control in meningiomas. Int J Radiat Oncol Biol Phys 1988; 15: 501-504.
30. SCHRELL UMH, RITTIG MG, ANDERS M, KIESEWETTER F, MARSCHALEK R, KOCH UH, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I- Inhibition of primary human meningioma cell in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 1997; 86: 845-852.
31. SCHRELL UMH, RITTIG MG, ANDERS M, KOCH UH, MARSCHALEK R, KIESEWETTER F, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II- Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 1997; 86: 840-844.
32. SEKHAR LN, BUCHANAN RI, WRIGHT DC, BROEMELING LD. Benign tumors of the cavernous sinus. The case for aggressive resection. Clin Neurosurg 1999; 45: 263-278.
33. SEKHAR LN, WRIGHT DC, RICHARDSON R, MONACCI W. Petroclival and foramen magnum meningiomas: surgical approaches and pitfalls. J Neurooncol 1996; 29: 249-259.
34. SIMPSON D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatr 1957; 20: 22-39.